Chemoinformaics analysis of 5-Epideoxyloganic acid
Molecular Weight | 360.359 | nRot | 4 |
Heavy Atom Molecular Weight | 336.167 | nRig | 17 |
Exact Molecular Weight | 360.142 | nRing | 3 |
Solubility: LogS | -0.668 | nHRing | 2 |
Solubility: LogP | -0.745 | No. of Aliphatic Rings | 3 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 16 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
nHA | 8 | APOL | 49.941 |
nHD | 5 | BPOL | 30.153 |
QED | 0.417 |
Synth | 4.597 |
Natural Product Likeliness | 2.858 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.017 |
HIA | 0.939 |
CACO-2 | -6.054 |
MDCK | 0.00015112 |
BBB | 0.659 |
PPB | 0.218512 |
VDSS | 0.293 |
FU | 0.576754 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.044 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.066 |
CYP2c9-inh | 0.002 |
CYP2c9-sub | 0.173 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.124 |
CYP3a4-inh | 0.007 |
CYP3a4-sub | 0.069 |
CL | 1.612 |
T12 | 0.559 |
hERG | 0.029 |
Ames | 0.051 |
ROA | 0.23 |
SkinSen | 0.029 |
Carcinogencity | 0.922 |
EI | 0.008 |
Respiratory | 0.202 |
NR-Aromatase | 0.002 |
Antiviral | Yes |
Prediction | 0.796793 |